Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Among authors: filgueiras ps. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
Booster dose of BNT162b2 after two doses of CoronaVac improves neutralization of SARS-CoV-2 Omicron variant.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, de Souza Silva TB, Alves PA, da Rocha Fernandes G, de Oliveira JG, Rahal P, Grenfell RFQ, Nogueira ML. Campos GRF, et al. Among authors: filgueiras ps. Commun Med (Lond). 2022 Jun 29;2:76. doi: 10.1038/s43856-022-00141-4. eCollection 2022. Commun Med (Lond). 2022. PMID: 35784447 Free PMC article.
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras PS, Corsini CA, Almeida NBF, Pedrosa MLC, Miranda DAP, Gomes SVC, Assis JV, Silva RA, Medeiros MIVARC, Lourenço AJ, Bicalho CMF, Vilela RVR, Jeremias WJ, Fernandes GDR, Queiroz RFGE. Filgueiras PS, et al. Rev Soc Bras Med Trop. 2023 May 22;56:e01672022. doi: 10.1590/0037-8682-0167-2022. eCollection 2023. Rev Soc Bras Med Trop. 2023. PMID: 37222349 Free PMC article.
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Corsini CA, Filgueiras PS, Almeida NB, Miranda DA, Gomes SV, Lourenço AJ, Bicalho CM, Assis JV, Amorim RN, Silva RA, Vilela RV, Lima TM, Abreu DP, Alvim RG, Castilho LR, Martins-Filho OA, Otta DA, Grenfell RF. Corsini CA, et al. Among authors: filgueiras ps. Sci Rep. 2023 Oct 30;13(1):18606. doi: 10.1038/s41598-023-43263-y. Sci Rep. 2023. PMID: 37903875 Free PMC article.
Immunogenicity and safety of CoronaVac vaccine in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, da Silva Martins PF, Filgueiras PS, Lourenço AJ, de Souza Lima AE, Gomes SVC, de Jesus Jeremias W, Alves PA, da Rocha Fernandes G, Castro LLME, Teixeira-Carvalho A, Azevedo ACC, De Almeida Leitao Curimbaba C, Lorencini DA, Junior EM, da Silva VM, Cervi MC, de Carvalho Borges M, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, de Sousa Reis EV, Dos Reis Castilho L, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM; Immunita Team; Grenfell RFQE. Corsini CA, et al. Among authors: filgueiras ps. Sci Rep. 2025 Jul 2;15(1):23040. doi: 10.1038/s41598-025-94596-9. Sci Rep. 2025. PMID: 40595400 Free PMC article. Clinical Trial.
Second booster dose improves antibody neutralization against BA.1, BA.5 and BQ.1.1 in individuals previously immunized with CoronaVac plus BNT162B2 booster protocol.
Campos GRF, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, de Assis JV, Silva TBS, Alves PA, Fernandes GDR, de Oliveira JG, Rahal P, Grenfell RFQ, Nogueira ML. Campos GRF, et al. Among authors: filgueiras ps. Front Cell Infect Microbiol. 2024 Apr 4;14:1371695. doi: 10.3389/fcimb.2024.1371695. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38638823 Free PMC article.
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, Martins PFDS, Filgueiras PS, Lourenço AJ, Lima AES, Gomes SVC, Jeremias WJ, Alves PA, Fernandes GDR, Castro LLME, de Carvalho AT, Azevedo ACC, Curimbaba CAL, Lorencini DA, Junior EM, da Silva VM, Cervi MC, Borges MC, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, Reis EVS, Castilho LDR, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM, Grenfell RFQE; Immunita team. Corsini CA, et al. Among authors: filgueiras ps. Res Sq [Preprint]. 2024 Feb 29:rs.3.rs-3931021. doi: 10.21203/rs.3.rs-3931021/v1. Res Sq. 2024. PMID: 38464059 Free PMC article. Preprint.
11 results